• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis.促红细胞生成素对接受血液透析的骨髓瘤患者贫血的影响。
BMJ. 1990 Sep 8;301(6750):476-7. doi: 10.1136/bmj.301.6750.476.
2
Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.重组促红细胞生成素在一名血液透析患者多发性骨髓瘤相关性贫血治疗中的应用
Nephrol Dial Transplant. 1994;9(7):876-7.
3
Erythropoietin (r-HuEPO) for the treatment of anaemia in patients with multiple myeloma and end-stage renal failure.促红细胞生成素（重组人促红细胞生成素）用于治疗多发性骨髓瘤和终末期肾衰竭患者的贫血。
Nephrol Dial Transplant. 1995 Dec;10(12):2374-5. doi: 10.1093/ndt/10.12.2374b.
4
[Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].重组人促红细胞生成素治疗合并肾衰竭的多发性骨髓瘤贫血
An Med Interna. 1995 Apr;12(4):187-8.
5
Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?促红细胞生成素治疗对接受血液透析的骨髓瘤患者是否安全有效？
Clin Nephrol. 1993 Sep;40(3):176-8.
6
Practical guidelines for the use of NESP in treating renal anaemia.
Nephrol Dial Transplant. 2001;16 Suppl 3:22-8. doi: 10.1093/ndt/16.suppl_3.22.
7
Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.重组人促红细胞生成素（rHuEPO）治疗慢性肾衰竭（CRF）患者贫血：一组接受慢性血液透析治疗患者的经验
Transplant Proc. 1991 Apr;23(2):1833-4.
8
Effects of withdrawing erythropoietin.停用促红细胞生成素的影响。
BMJ. 1991 Feb 2;302(6771):272-3. doi: 10.1136/bmj.302.6771.272-a.
9
Association between haemoglobin and neopterin concentrations in haemodialysis patients treated with erythropoietin.接受促红细胞生成素治疗的血液透析患者血红蛋白与新蝶呤浓度之间的关联。
Eur J Haematol. 1993 Sep;51(3):175-6. doi: 10.1111/j.1600-0609.1993.tb00621.x.
10
Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.重组人促红细胞生成素治疗慢性血液透析患者贫血
Czech Med. 1990;13(2-3):98-106.

引用本文的文献

1
Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.促红细胞生成素：关于其在慢性肾衰竭中的应用及其对生活质量影响的药物经济学综述。
Pharmacoeconomics. 1993 Jan;3(1):45-82. doi: 10.2165/00019053-199303010-00006.
2
Increased plasma viscosity as a reason for inappropriate erythropoietin formation.
J Clin Invest. 1993 Jan;91(1):251-6. doi: 10.1172/JCI116178.
3
Nephrology, dialysis and transplantation.肾脏病学、透析与移植
Postgrad Med J. 1993 Jul;69(813):516-46. doi: 10.1136/pgmj.69.813.516.
4
The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse.重组人促红细胞生成素治疗对小鼠肿瘤放射敏感性及癌性贫血的影响。
Br J Cancer. 1993 Oct;68(4):720-6. doi: 10.1038/bjc.1993.417.
5
Effect of erythropoietin in patients with myeloma.促红细胞生成素对骨髓瘤患者的影响。
BMJ. 1990 Sep 29;301(6753):667. doi: 10.1136/bmj.301.6753.667-a.

本文引用的文献

1
Anaemia in patients with myelomatosis.骨髓瘤患者的贫血
Br J Cancer. 1982 Jun;45(6):887-94. doi: 10.1038/bjc.1982.141.
2
Identification of tissues and cells producing erythropoietin in the anemic mouse.
Contrib Nephrol. 1988;66:17-24. doi: 10.1159/000416000.
3
Dialysis in the management of the renal failure of myeloma.透析在骨髓瘤肾衰竭管理中的应用
Q J Med. 1989 Oct;73(270):871-2.

Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis.

作者信息

Taylor J, Mactier R A, Stewart W K, Henderson I S

机构信息

Renal Unit, Ninewells Hospital and Medical School, Dundee.

出版信息

BMJ. 1990 Sep 8;301(6750):476-7. doi: 10.1136/bmj.301.6750.476.

DOI:10.1136/bmj.301.6750.476
PMID:2207402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1663757/
Abstract
摘要